血管内超声探测的衰减斑块对经皮冠状动脉介入治疗患者术中及术后的影响:12个月临床随访结果One year follow-up of attenuated plaques detected by IVUS during percutaneous coronary intervention
贾若飞,朱华刚,李响,杨铎,李红,韩静,宋荟芬,金泽宁
摘要(Abstract):
目的对急性心肌梗死(AMI)患者行血管内超声(IVUS)检查探测衰减斑块,观察及探讨衰减斑块患者行经皮冠状动脉介入治疗(PCI)术中情况及术后12个月临床随访结果。方法纳入2012年12月至2014年4月北京安贞医院急诊危重症中心收治的急性心肌梗死患者85例,行冠状动脉造影并进行IVUS检查,必要时行PCI术。根据IVUS是否探测到衰减斑块将患者分为衰减斑块组和非衰减斑块组,比较两组患者围术期IVUS影像学结果。球囊扩张术后TIMI血流情况及术后12个月主要不良心脑血管事件(MACCE)发生率。结果 85例AMI患者IVUS检测结果分为衰减斑块组35例(41.2%),非衰减斑块组50例(58.8%)。两组患者年龄、性别、合并糖尿病、合并高血压病、低密度脂蛋白胆固醇等方面比较,差异均无统计学意义(均P>0.05);衰减斑块组患者脑钠肽显著低于非衰减斑块组[(55.92±10.27)pg/ml比(60.32±9.22)pg/ml,P=0.029],差异有统计学意义。两组患者术前TIMI血流分级比较,差异均无统计学意义(P>0.05);但在球囊扩张术后,衰减斑块组患者TIMI血流0~Ⅱ级比例(37.1%比10.0%,P=0.003)显著高于非衰减斑块组,差异有统计学意义。IVUS探测下衰减斑块组患者病变血管截面积[(15.48±3.22)mm~2比(11.71±3.01)mm~2,P<0.001]、斑块面积[(14.40±4.11)mm~2比(10.69±2.85)mm~2,P<0.001]、斑块负荷[(87.42±3.83)mm~2比(80.14±4.18)mm~2,P<0.001]、参考血管截面积[(14.18±3.12)mm~2比(11.22±2.89)mm~2,P<0.001]、偏心性(68.6%比36.0%,P<0.001)显著大于非衰减斑块组,差异均有统计学意义。术后随访12个月,两组患者总MACCE发生率比较,差异无统计学意义(P>0.05)。结论在IVUS探测下发现的衰减斑块,可导致球囊扩张术后无复流及慢血流发生率的增加。
关键词(KeyWords): 衰减斑块;血管内超声;主要不良心脑血管事件;靶血管再次血运重建
基金项目(Foundation):
作者(Author): 贾若飞,朱华刚,李响,杨铎,李红,韩静,宋荟芬,金泽宁
参考文献(References):
- [1]Abdelmeguid AE,Topol EJ,Whitlow PL,et al.Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions.Circulation,1996,94(7):1528-1536.
- [2]Piana RN,Paik GY,Moscucci M,et al.Incidence and treatment ofno-reflowafter percutaneous coronary intervention.Circulation,1994,89(6):2514-2518.
- [3]Abbo KM,Dooris M,Glazier S,et al.Features and outcome of no-reflow after percutaneous coronary intervention.Am J Cardiol,1995,75(12):778-782.
- [4]刘健,韩雅君,王伟民,等.急性心肌梗死介入治疗后慢血流现象的血管内超声影像分析.中国介入心脏病学杂志,2011,19(1):20-23.
- [5]Pu J,Mintz GS,Brilakis ES,et al.In vivo characterization of coronary plaques:novel findings from comparing greyscale and virtual histology intravascular ultrasound and near-infrared spectroscopy.Eur Heart J,2012,33(3):372-383.
- [6]The TIMI Study Group.The thrombolysis in myocardial infarction(TIMI)trial.N Engl J Med,1985,312(14):932-936.
- [7]Gibson CM,Cannon CP,Daley WL,et al.TIMI frame count:a quantitative method of assessing coronary artery flow.Circulation,1996,93(5):879-888.
- [8]Shiono Y,Kubo T,Tanaka A,et al.Impact of attenuated plaque as detected by intravascular ultrasound on the occurrence of microvascular obstruction after percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.JACC Cardiovasc Interv,2013,6(8):847-853.
- [9]Hara H,Tsunoda T,Moroi M,et al.Ultrasound attenuation behind coronary atheroma without calcification:mechanism revealed by autopsy.Acute Card Care,2006,8(2):110-112.
- [10]Kimura S,Kakuta T,Yonetsu T,et al.Clinical significance of echo signal attenuation on intravascular ultrasound in patients with coronary artery disease.Circ Cardiovasc Interv,2009,2(5):444-454.
- [11]Hara H,Tsunoda T,Moroi M,et al.Ultrasound attenuation behind coronary atheroma without calcification:mechanism revealed by autopsy.Acute Card Care,2006,8(2):110-112.
- [12]Akyildiz AC,Speelman L,van Brummelen H,et al.Effects of intima stiffness and plaque morphology on peak cap stress.Biomed Eng Online,2011,10:25.
- [13]Kawaguchi R,Oshima S,Jingu M,et al.Usefulness of virtual histology intravascular ultrasound to predict distal embolization for ST-segment elevation myocardial infarction.J Am Coll Cardiol,2007,50(17):1641-1646.
- [14]Hong YJ,Jeong MH,Choi YH,et al.Impact of plaque components on no-reflow phenomenon after stent deployment in patients with acute coronary syndrome:a virtual histologyintravascular ultrasound analysis.Eur Heart J,2009,32(16):2059-2066
- [15]Davies MJ,Richardson PD,Woolf N,et al.Risk of thrombosis in human atherosclerotic plaques:role of extracellular lipid,macrophage,and smooth muscle cell content.Br Heart J,1993,69(5):377-381.
- [16]Ding S,Xu L,Yang F,et al.Association between tissue characteristics of coronary plaque and distal embolization after coronary intervention in acute coronary syndrome patients:insights from a meta-analysis of virtual histology-intravascular ultrasound studies.PLo S One,2014,9(11):e106583.
- [17]Wu X,Mintz GS,Xu K,et al.The relationship between attenuated plaque identified by intravascular ultrasound and noreflow after stenting in acute myocardial infarction:The HORIZONS-AMI(Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction)trial.JACC Cardiovasc Interv,2011,4(5):495-502.
- [18]Stone GW,Maehara A,Lansky AJ,et al.A prospective naturalhistory study of coronary atherosclerosis.N Engl J Med,2011,364(3):226-235.
- [19]Sakata Y,Kodama K,Ishikura F,,et al.Disappearance of the‘no-reflow’phenomenon after adjunctive intracoronary administration of nicorandil in a patient with acute myocardial infarction.Jpn Circ J,61(5):455-458.
- [20]Iwasaki K,Samukawa M,Furukawa H.Comparison of the effects of nicorandil versus verapamil on the incidence of slow flow/no reflow during rotational atherectomy.Am J Cardiol,2006,98(10):1354-1356.
- [21]Wang HJ,Lo PH,Lin JJ,et al.Treatment of slow/no-reflow phenomenon with intracoronary nitroprusside injection in primary coronary intervention for acute myocardial infarction.Catheter Cardiovasc Interv,2004,63(2):171-176.
- [22]Kotani J,Nanto S,Mintz GS,et al.Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome.Circulation,2002,106(13):1672-1677.